Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “therapy”

782 pharma patents match "therapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 782
Index total 30,257
Page 21 / 33

Quick answer

This filtered view shows 782 pharmaceutical patents matching "therapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

782 results for “therapy” · 30,257 patents in full index Clear search

  1. US 9687522

    Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 27, 2017 · Expires Jun 22, 2037

    granted
  2. US 9682080

    Pyruvate kinase activators for use in therapy

    Agios Pharmaceuticals, Inc. · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  3. US 9670549

    Gene expression signatures of neoplasm responsiveness to therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  4. US 9655909

    Personalized medicine for the prediction of therapy targeting the hedgehog pathway

    The Board of Regents of the University of Texas System · Granted May 23, 2017 · Expires May 18, 2037

    granted
  5. US 9651562

    Cathelicidin as novel inflammatory bowel disease marker and therapy for colitis associated intestinal fibrosis

    The Regents of the University of California · Granted May 16, 2017 · Expires May 11, 2037

    granted
  6. US 9642805

    Aptamer-loaded, biocompatible nanoconstructs for nuclear-targeted cancer therapy

    Northwestern University · Granted May 9, 2017 · Expires May 4, 2037

    granted
  7. US 9629899

    Targeted cargo protein combination therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted
  8. US 9616107

    Therapy for kidney disease and/or heart failure

    Capricor Therapeutics, Inc. · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted
  9. US 9597336

    Therapy for treatment of chronic degenerative brain diseases and nervous system injury

    The Regents of the University of California · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  10. US 9596855

    Small molecule inhibitors of biofilm formation and the novel use of previously identified compounds for inhibition of biofilm formation and applications for drug therapy and medical device coating

    The Regents of the University of California · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  11. US 9592290

    Monoclonal antibody therapy for pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  12. US 9572881

    Halogenated compounds for photodynamic therapy

    NANOQUANTUM SCIENCES, INC. · Granted Feb 21, 2017 · Expires Feb 16, 2037

    granted
  13. US 9572809

    Combination therapy to treat Mycobacterium diseases

    SPERO TRINEM, INC. · Granted Feb 21, 2017 · Expires Feb 16, 2037

    granted
  14. US 9555037

    Method of using vasoconstrictive agents during energy-based tissue therapy

    Covidien LP · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  15. US 9551713

    Use of a panel of urinary cytokines to predict response to BCG therapy for bladder cancer

    The Board of Regents of the University of Texas System · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  16. US 9549995

    Efficient synthesis of ethylenedicysteine-sugar conjugates for imaging and therapy

    The Board of Regents of the University of Texas System · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  17. US 9533025

    Method for treating chemotherapy-induced male infertility

    The Board of Regents of the University of Texas System · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted
  18. US 9533045

    Photothermal therapy using magnetic nanoparticles

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted
  19. US 9522137

    Methods for dosing an orally active 1,2,4-Oxadiazole for nonsense mutation suppression therapy

    PTC THERAPEUTICS, INC. · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted
  20. US 9517275

    Targeted therapy for the prevention of restenosis in the cardiovascular system

    Northwestern University · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  21. US 9512401

    B and T lymphocyte attenuator marker for use in adoptive T-cell therapy

    The Board of Regents of the University of Texas System · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  22. US 9492564

    Dual specific immunotoxin for brain tumor therapy

    The United States of America as Represented by the Secretary of Health and Human Services, National Institutes of Health · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  23. US 9486474

    Interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis

    The Regents of the University of California · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  24. US 9470689

    N-cadherin: target for cancer diagnosis and therapy

    The Regents of the University of California · Granted Oct 18, 2016 · Expires Oct 13, 2036

    granted